Pale Fire Capital SE Makes New $374,000 Investment in Tenet Healthcare Corporation $THC

Posted by George Bondi on Sep 3rd, 2026

Pale Fire Capital SE acquired a new stake in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,000 shares of the company’s stock, valued at approximately $374,000.

A number of other institutional investors also recently bought and sold shares of the stock. Triumph Capital Management acquired a new position in Tenet Healthcare during the 3rd quarter valued at approximately $25,000. Elyxium Wealth LLC purchased a new stake in shares of Tenet Healthcare during the fourth quarter valued at $29,000. Meeder Asset Management Inc. increased its position in shares of Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after acquiring an additional 114 shares during the period. Trust Co. of Vermont purchased a new position in Tenet Healthcare in the 2nd quarter worth $37,000. Finally, Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare during the 2nd quarter valued at about $35,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

NYSE:THC opened at $258.79 on Thursday. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The company has a 50 day moving average price of $234.93 and a 200-day moving average price of $210.62. Tenet Healthcare Corporation has a 1-year low of $157.58 and a 1-year high of $283.05. The firm has a market cap of $20.84 billion, a price-to-earnings ratio of 9.98, a price-to-earnings-growth ratio of 1.01 and a beta of 1.23.

Tenet Healthcare (NYSE:THC – Get Free Report) last released its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The company had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.Tenet Healthcare’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities research analysts forecast that Tenet Healthcare Corporation will post 21.04 EPS for the current year.

Insider Activity at Tenet Healthcare

In other news, Director Roy Blunt sold 600 shares of the business’s stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $262.68, for a total transaction of $157,608.00. Following the transaction, the director directly owned 4,589 shares in the company, valued at $1,205,438.52. The trade was a 11.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Lisa Y. Foo sold 24,000 shares of the business’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $266.32, for a total value of $6,391,680.00. Following the transaction, the executive vice president directly owned 8,053 shares in the company, valued at $2,144,674.96. This trade represents a 74.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 108,037 shares of company stock worth $28,965,972 in the last 90 days. 0.97% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on THC shares. Barclays raised their price objective on Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a research note on Friday, July 24th. UBS Group increased their price target on shares of Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Mizuho set a $290.00 price target on shares of Tenet Healthcare in a research report on Monday, August 10th. Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. Finally, Morgan Stanley increased their price objective on shares of Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday, July 27th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $273.00.

Check Out Our Latest Stock Report on THC

Tenet Healthcare Profile

(Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.